{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:54:10Z","timestamp":1781636050095,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The optimal approach for early-stage ovarian cancer detection remains unclear, particularly in patients with hereditary breast and ovarian cancer (HBOC). As ovarian cancer in HBOC is often thought to originate from the fallopian tube fimbriae, endometrial cytology may play a role in detecting early-stage disease. This retrospective study aimed to assess the positive rate of endometrial cytology and compare to cervical cytology in ovarian cancer patients with patients with BRCA1\/2 germline pathogenic variants (gPV).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients with genetically confirmed\n                      <jats:italic>BRCA1\/2<\/jats:italic>\n                      gPV diagnosed with ovarian, fallopian tube, or primary peritoneal cancer from May 1998 to April 2024 at our institution were included. Those who underwent endometrial and cervical cytology prior to initial treatment were eligible for this analysis. The positive rates for each cytology type were evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 154 patients with\n                      <jats:italic>BRCA1\/2<\/jats:italic>\n                      gPV were enrolled, 118 underwent both endometrial and cervical cytology. The positive rate for endometrial cytology was significantly higher than that for cervical cytology (36.4% vs. 15.3%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Additionally, a correlation was observed between the positive rate of endometrial cytology and cancer stage (Stage I 16.6%, Stage II 25%, Stage III 41.5%, Stage IV 58.6%;\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.9895).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In this retrospective study, the positive rate of endometrial cytology surpassed that of cervical cytology. Endometrial cytology may play a role as a potential surveillance tool for women with\n                      <jats:italic>BRCA1\/2<\/jats:italic>\n                      gPV, even at early stages of ovarian cancer.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43046-026-00344-z","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:03:40Z","timestamp":1771200220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Positive rates of endometrial and cervical cytology in ovarian cancer patients with BRCA1\/2 germline pathogenic variants"],"prefix":"10.1186","volume":"38","author":[{"given":"Eitaro","family":"Funada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Kon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Kuratomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Fusegi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiho","family":"Netsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Omi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terumi","family":"Tanigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanshiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Yunokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tonooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kanao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"344_CR1","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"ND Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L. Risk-reducing salpingo-oophorectomy in women with BRCA1 or BRCA2 mutation. N Engl J Med. 2002;346:1609\u201315. https:\/\/doi.org\/10.1056\/NEJMoa020119.","journal-title":"N Engl J Med"},{"key":"344_CR2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","volume":"387","author":"IJ Jacobs","year":"2016","unstructured":"Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, Amso NN, Apostolidou S, Benjamin E, Cruickshank D, Crump DN. Ovarian cancer screening and mortality in the UK collaborative trial of ovarian cancer screening (UKCTOCS): a randomized controlled trial. Lancet. 2016;387:945\u201356.","journal-title":"Lancet"},{"key":"344_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1200\/JCO.2011.39.763","volume":"31","author":"AN Rosenthal","year":"2013","unstructured":"Rosenthal AN, Fraser L, Manchanda R, Badman P, Philpott S, Mozersky J, Hadwin R, Cafferty FH, Benjamin E, Singh N, Evans DG. Results of annual screening in phase I of the united Kingdom Familial ovarian cancer screening study highlight the need for strict adherence to screening schedule. Am Soc Clin Oncol. 2013;31:49\u201357. https:\/\/doi.org\/10.1200\/JCO.2011.39.763.","journal-title":"Am Soc Clin Oncol"},{"key":"344_CR4","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1200\/JCO.2016.69.9330","volume":"35","author":"AN Rosenthal","year":"2017","unstructured":"Rosenthal AN, Fraser LS, Philpott S, Manchanda R, Burnell M, Badman P, Hadwin R, Rizzuto I, Benjamin E, Singh N, Evans DG. Evidence of stage shift in women diagnosed with ovarian cancer during phase II of the united Kingdom Familial ovarian cancer screening study. Am Soc Clin Oncol. 2017;35:1411\u201320. https:\/\/doi.org\/10.1200\/JCO.2016.69.9330.","journal-title":"Am Soc Clin Oncol"},{"key":"344_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s13691-013-0082-1","volume":"2","author":"H Nomura","year":"2013","unstructured":"Nomura H, Abe A, Yamamoto A, Matoda M, Omatsu K, Kato K, Umayahara K, Furuta R, Takeshima N. A case of recurrent fallopian tube carcinoma in situ with para-aortic lymph node metastasis. Int Canc Conf J. 2013;2:161\u20134. https:\/\/doi.org\/10.1007\/s13691-013-0082-1.","journal-title":"Int Canc Conf J"},{"key":"344_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/jog.15935","volume":"50","author":"A Fusegi","year":"2024","unstructured":"Fusegi A, Nomura H, Ueki A, Abe A, Kamata M, Misaka S, Aoki Y, Tanigawa T, Yunokawa M, Kanao H. Ovarian surveillance including endometrial cytology for patients with hereditary breast and ovarian cancer before risk-reducing salpingo-oophorectomy: a retrospective analysis. J Obstet Gynaecol Res. 2024;50:1002\u20139. https:\/\/doi.org\/10.1111\/jog.15935.","journal-title":"J Obstet Gynaecol Res"},{"key":"344_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/joc.joc_49_22","volume":"40","author":"T Wang","year":"2023","unstructured":"Wang T, Bin Y, Zhao L, Li Q. Positive rate of malignant cells in endometrial cytology samples of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer patients: a systematic review and meta-analysis. J Cytol. 2023;40:51\u20137. https:\/\/doi.org\/10.4103\/joc.joc_49_22.","journal-title":"J Cytol"},{"key":"344_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","volume":"34","author":"RJ Kurman","year":"2010","unstructured":"Kurman RJ, Shih IM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433\u201343. https:\/\/doi.org\/10.1097\/PAS.0b013e3181cf3d79.","journal-title":"Am J Surg Pathol"},{"key":"344_CR9","doi-asserted-by":"publisher","first-page":"e40481","DOI":"10.7759\/cureus.40481","volume":"15","author":"YH Su","year":"2023","unstructured":"Su YH, Su HW, Liu CK, Lu CH, Hsu ST. Early-stage, BRCA-associated ovarian cancer detected by Papanicolaou smear: a case report. Cureus. 2023;15:e40481. https:\/\/doi.org\/10.7759\/cureus.40481.","journal-title":"Cureus"},{"key":"344_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/dc.23957","volume":"277","author":"O Nwanodi","year":"2008","unstructured":"Nwanodi O, Choi C, Khulpateea N. Cervicovaginal cytology and diagnosis of ovarian or peritoneal cancer: case report and literature review. Arch Gynecol Obstet. 2008;277:171\u20134. https:\/\/doi.org\/10.1002\/dc.23957.","journal-title":"Arch Gynecol Obstet"},{"key":"344_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/dc.23957","volume":"46","author":"M Shintaku","year":"2018","unstructured":"Shintaku M, Taniguchi H, Yamamoto Y, Kono F, Sumitomo M. Detection of tumor cells of serous tubal intraepithelial carcinoma (STIC) in cervical smears and rapid development of the ovarian involvement: a case report. Diagn Cytopathol. 2018;46:945\u20139.","journal-title":"Diagn Cytopathol"},{"key":"344_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2016.00108","volume":"108","author":"SH George","year":"2016","unstructured":"George SH, Garcia R, Slomovitz BM. Ovarian cancer: the fallopian tube as the site of origin and opportunities for prevention. Front Oncol 6:Article. 2016;108:1\u20137. https:\/\/doi.org\/10.3389\/fonc.2016.00108.","journal-title":"Front Oncol 6:Article"},{"key":"344_CR13","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1159\/000332857","volume":"41","author":"N Takeshima","year":"1997","unstructured":"Takeshima N, Hirai Y, Yamauchi K, Hasumi K. Clinical usefulness of endometrial aspiration cytology and CA-125 in the detection of fallopian tube carcinoma. Acta Cytol. 1997;41:1445\u201350. https:\/\/doi.org\/10.1159\/000332857.","journal-title":"Acta Cytol"},{"key":"344_CR14","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","volume":"30","author":"F Medeiros","year":"2006","unstructured":"Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, Garber JE, Cramer DW, Crum CP. The tubal fimbria is a preferred site for early adenocarcinoma in women with Familial ovarian cancer syndrome. Am J Surg Pathol. 2006;30:230\u20136. https:\/\/doi.org\/10.1097\/01.pas.0000180854.28831.77.","journal-title":"Am J Surg Pathol"},{"key":"344_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.fertnstert.2019.03.028","volume":"112","author":"AM Abbas","year":"2019","unstructured":"Abbas AM, Samy A, Abd El-Gaber AE, Khodry MM, Ahmed MA, El-Rasheedy MI, Abdallah KM, Mohammed AE, Abdelbaky WH, Raslan OK, Badawy MA. Medications for pain relief in outpatient endometrial sampling or biopsy: a systematic review and network meta-analysis. Fertil Steril. 2019;112:140\u20138. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.03.028.","journal-title":"Fertil Steril"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00344-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00344-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00344-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:09:31Z","timestamp":1781633371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43046-026-00344-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["344"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00344-z","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study protocol was reviewed and approved by the Institutional Review Board (IRB) of Cancer Institute Hospital of Japanese Foundation for Cancer Research, and the IRB number is 2023-GB-109.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent has been obtained from all individuals included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}